Atlas Trials

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Clinical trial NCT04981119 · RECRUITING

Trial details

NCT number
NCT04981119
Sponsor
A2 Biotherapeutics Inc.
Status
RECRUITING
Study type
OBSERVATIONAL
Solid Tumor, AdultColorectal CancerNon Small Cell Lung CancerPancreatic CancerCRCNSCLCPancreas CancerMesotheliomaOvarian CancerOvarian NeoplasmsOvarian CarcinomaMesothelioma, Malignant
Start date
2021-10-29
Primary completion
2028-12-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.